Content Status

Type

H5Content
Content

Adverse Drug Reactions (ADRs), such as psychotic symptoms, may occur from the Drug-resistant TB (DR-TB) treatment regimen.

 

Suspected agent(s): Cycloserine (Cs), Isoniazid (H), Fluoroquinolone (FQ)

 

Suggested Management Strategies

 

  • Stop the suspected agent for a short period (1-4 weeks) while the psychotic symptoms are brought under control. 
  • The most likely drug is Cs followed by high dose isoniazid (Hh). Lower the dose/ discontinue the suspected agent (if it can be done without compromising the regimen).
  • If moderate to severe symptoms persist, initiate antipsychotic treatment (haloperidol)
  • Hospitalize in a ward with psychiatric expertise if the patient is at risk to hurt himself/ herself or others.
  • Once all the symptoms resolve and the patient is off Cs, antipsychotic treatment can be tapered off. 
  • If Cs is continued at a lower dose, antipsychotic treatment may need to be continued and any attempts of tapering off should be done after referring to a psychiatrist trained in the adverse effects of second-line anti-TB drugs.

 

Point to Note

 

  • Some patients will be required to continue antipsychotic treatment.
  • A previous history of psychiatric disease is not an absolute contraindication to Cs, but its use may increase the likelihood of psychotic symptoms that are found to be developing during treatment.
  • Some patients will tolerate Cs with an antipsychotic drug, but this should be done in consultation with a psychiatrist as these patients will be required to be under special observation; this should be done only when there is no other alternative.
  • Psychotic symptoms are generally reversible upon completion of DR-TB treatment or cessation of the offending agent.
  • Always check creatinine in patients with new-onset psychosis. A decrease in renal function can result in high blood levels of Cs, which can cause psychosis.

 

​Resources

 

 

Kindly provide your valuable feedback on the page to the link provided HERE

Content Creator

Reviewer